莫诺拉韦多少钱一盒？

In March 2020, the World Health Organization (WHO) declared COVID-19 a global pandemic. As of June 2022, according to WHO statistics, the number of confirmed cases worldwide has exceeded 500 million, and more than 6 million people have died as a result, posing a huge challenge to global public health. After the COVID-19 outbreak, DRIVE licensed (Molnupiravir) to the pharmaceutical company Ridgeback Biotherapeutics, which was jointly developed by Ridgeback Biotherapeutics and Merck & Co. (MSD) for the treatment of COVID-19. Follow-up studies have found that Molnupiravir not only effectively inhibits the replication of SARS-CoV-2 both in vivo and in vitro, but also inhibits the transmission of SARS-CoV-2 from infected ferrets to uninfected ferrets. So, how much does a box of Monoravir cost?

Monoravir Price

The overseas pricing of monogravir is higher than that of Paxlovid. Paxlovid costs about US$530 for a course of treatment, while a course of monogravir costs about US$700. The price can be said to be very expensive, but it is understood that the overseas version of Monupivir/Monoravir/Monapiravir is only 350$, which is sought after by many domestic patients.

How to buy Monoravir

The drug is currently available for purchase in China, but the price is expensive and has not yet been determined. There is news that the price of Paxlovid when it first entered the Chinese market is less than 2,980 US dollars per box, and the price of monogravir is estimated to be around 4,000 US dollars. This is not friendly to low-income patients and families, and the drug is not covered by medical insurance. Therefore, qualified patients can choose to purchase monogravir domestically. But patients can still choose the overseas version of monogravir, after all, the price is too friendly.

Patients can trust domestic and overseas medical service organizations to help purchase monogravir and sign a three-party contract. Firstly, the quality of the drug is guaranteed, and secondly, overseas direct mail is fast and convenient. It is not recommended that patients look for purchasing agents as it is easy to be deceived.

Recommended hot articles: